FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4255436701> ?p ?o ?g. }

• W4255436701 abstract "<sec> <title>BACKGROUND</title> Parkinson disease (PD) is a neurodegenerative disorder associated with a broad spectrum of motor and nonmotor symptoms. Any proposed cure needs to address the many aspects of the disease. Stem cell therapy may have potential in this regard as indicated in recent preclinical and clinical studies. </sec> <sec> <title>OBJECTIVE</title> This protocol aims to examine the safety and therapeutic benefit of human Wharton jelly-derived mesenchymal stem cells (WJ-MScs) and their derivatives, neuronal stem cells (NSCs) in PD. </sec> <sec> <title>METHODS</title> This clinical trial is a double-arm, single-blinded, phase I-II interventional study. Participants have been allocated to 1 of 2 groups: one receiving allogeneic WJ-MSCs alone, the other receiving NSCs and WJ-MScs. Participants are being followed-up and assessed over a period of 6 months. To assess safety, an incidence of treatment-emergent adverse events (TEAEs) tool tailored for PD is being used immediately and up to 6 months after treatment. For efficacy assessment, a number of factors are being used, including the gold standard severity test and the Unified Parkinson Disease Rating Scale. In addition, the following standardized assessments for different common symptoms in PD are being included: motor (both subjectively and objectively assessed with wearable sensors), sensory, quality of life and psychological well-being, cognition, and sleep quality. Furthermore, immune-modulatory cytokines and neuronal damage versus regeneration markers in PD, including the neuronal protein linked to PD, α-synuclein, are being monitored. </sec> <sec> <title>RESULTS</title> Ten patients have been enrolled in this study and thus participant recruitment has been completed. The study status is active and beyond the recruiting stage. Study chart implementation, data collection, and analysis are ongoing. </sec> <sec> <title>CONCLUSIONS</title> The combination of NSCs and MSCs in PD may be useful for harnessing the best of the immunomodulation and neural repair characteristics of these cell types. The tailored comprehensive and scaled TEAEs and the variety of evaluation tools used enables a comprehensive assessment of this cellular therapy treatment protocol. A consideration of this expanded tool set is important in the design of future clinical studies for PD. </sec> <sec> <title>CLINICALTRIAL</title> ClinicalTrials.gov NCT03684122; https://clinicaltrials.gov/ct2/show/NCT03684122 </sec> <sec> <title>INTERNATIONAL REGISTERED REPORT</title> DERR1-10.2196/29695 </sec>" @default.
• W4255436701 created "2022-05-12" @default.
• W4255436701 creator A5018295808 @default.
• W4255436701 creator A5042192754 @default.
• W4255436701 creator A5062682073 @default.
• W4255436701 creator A5071280017 @default.
• W4255436701 creator A5078669634 @default.
• W4255436701 creator A5090582860 @default.
• W4255436701 date "2021-04-16" @default.
• W4255436701 modified "2023-09-26" @default.
• W4255436701 title "A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study (Preprint)" @default.
• W4255436701 cites W1610380626 @default.
• W4255436701 cites W1754615847 @default.
• W4255436701 cites W1866257816 @default.
• W4255436701 cites W1963643534 @default.
• W4255436701 cites W1968668812 @default.
• W4255436701 cites W2000113722 @default.
• W4255436701 cites W2000199490 @default.
• W4255436701 cites W2012946674 @default.
• W4255436701 cites W2025371271 @default.
• W4255436701 cites W2047701363 @default.
• W4255436701 cites W2052684906 @default.
• W4255436701 cites W2060979783 @default.
• W4255436701 cites W2064423185 @default.
• W4255436701 cites W2067256437 @default.
• W4255436701 cites W2074688729 @default.
• W4255436701 cites W2078011077 @default.
• W4255436701 cites W2093518077 @default.
• W4255436701 cites W2140391319 @default.
• W4255436701 cites W2161703366 @default.
• W4255436701 cites W2165758561 @default.
• W4255436701 cites W2171920636 @default.
• W4255436701 cites W2280304830 @default.
• W4255436701 cites W2346462490 @default.
• W4255436701 cites W2525903933 @default.
• W4255436701 cites W2530110801 @default.
• W4255436701 cites W2751008629 @default.
• W4255436701 cites W2757687260 @default.
• W4255436701 cites W2790928579 @default.
• W4255436701 cites W2800142452 @default.
• W4255436701 cites W2807049120 @default.
• W4255436701 cites W2886487705 @default.
• W4255436701 cites W2888254436 @default.
• W4255436701 cites W2890498338 @default.
• W4255436701 cites W2896544753 @default.
• W4255436701 cites W2913843269 @default.
• W4255436701 cites W2921897722 @default.
• W4255436701 cites W2942091494 @default.
• W4255436701 cites W2950509604 @default.
• W4255436701 cites W2970841768 @default.
• W4255436701 cites W2977150288 @default.
• W4255436701 cites W4205416135 @default.
• W4255436701 doi "https://doi.org/10.2196/preprints.29695" @default.
• W4255436701 hasPublicationYear "2021" @default.
• W4255436701 type Work @default.
• W4255436701 citedByCount "0" @default.
• W4255436701 crossrefType "posted-content" @default.
• W4255436701 hasAuthorship W4255436701A5018295808 @default.
• W4255436701 hasAuthorship W4255436701A5042192754 @default.
• W4255436701 hasAuthorship W4255436701A5062682073 @default.
• W4255436701 hasAuthorship W4255436701A5071280017 @default.
• W4255436701 hasAuthorship W4255436701A5078669634 @default.
• W4255436701 hasAuthorship W4255436701A5090582860 @default.
• W4255436701 hasConcept C126322002 @default.
• W4255436701 hasConcept C142724271 @default.
• W4255436701 hasConcept C143998085 @default.
• W4255436701 hasConcept C159110408 @default.
• W4255436701 hasConcept C197934379 @default.
• W4255436701 hasConcept C198826908 @default.
• W4255436701 hasConcept C2779134260 @default.
• W4255436701 hasConcept C2779734285 @default.
• W4255436701 hasConcept C2779951463 @default.
• W4255436701 hasConcept C28328180 @default.
• W4255436701 hasConcept C535046627 @default.
• W4255436701 hasConcept C54355233 @default.
• W4255436701 hasConcept C71924100 @default.
• W4255436701 hasConcept C86803240 @default.
• W4255436701 hasConceptScore W4255436701C126322002 @default.
• W4255436701 hasConceptScore W4255436701C142724271 @default.
• W4255436701 hasConceptScore W4255436701C143998085 @default.
• W4255436701 hasConceptScore W4255436701C159110408 @default.
• W4255436701 hasConceptScore W4255436701C197934379 @default.
• W4255436701 hasConceptScore W4255436701C198826908 @default.
• W4255436701 hasConceptScore W4255436701C2779134260 @default.
• W4255436701 hasConceptScore W4255436701C2779734285 @default.
• W4255436701 hasConceptScore W4255436701C2779951463 @default.
• W4255436701 hasConceptScore W4255436701C28328180 @default.
• W4255436701 hasConceptScore W4255436701C535046627 @default.
• W4255436701 hasConceptScore W4255436701C54355233 @default.
• W4255436701 hasConceptScore W4255436701C71924100 @default.
• W4255436701 hasConceptScore W4255436701C86803240 @default.
• W4255436701 hasLocation W42554367011 @default.
• W4255436701 hasOpenAccess W4255436701 @default.
• W4255436701 hasPrimaryLocation W42554367011 @default.
• W4255436701 hasRelatedWork W1606821450 @default.
• W4255436701 hasRelatedWork W2077588413 @default.
• W4255436701 hasRelatedWork W2394573997 @default.
• W4255436701 hasRelatedWork W2518309888 @default.
• W4255436701 hasRelatedWork W2931700031 @default.
• W4255436701 hasRelatedWork W3003022248 @default.

• next